EDSA Edesa: Earnings per share for the last twelve months
Edesa Biotech, Inc. (EDSA) is driving the dynamics of its rolling annual net income per share through large-scale investments in next-generation antibody development, where the parameter value equals -1.68. The company's environmental responsibility is evident in the modernization of laboratory filtration, while strict adherence to logistical protocols ensures the uninterrupted delivery of trial drugs. This chart captures the balance between the issuer's capacities and market demand.
Analytical breakdowns and data insights for company Edesa Biotech Inc (EDSA)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Edesa Biotech, Inc.|EDSA - Long-Term Liabilities to Capital|Short-Term Debt to Capital Edesa|EDSA - Company Cumulative Debt|Debts to Book Capitalization Edesa Biotech, Inc.|EDSA - Company Long-Term Indebtedness|Company Short-Term Debts Edesa Biotech|Quick Liquidity edesabiotech.com
- earnings and valuation multiples indicators:
EDSA - Net Financial Result|Projected Future Earnings Edesa Biotech, Inc.|EDSA - P/E Multiple|Projected Price to Earnings Edesa Biotech|EDSA - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Edesa Biotech, Inc.|EDSA - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Edesa Biotech|EDSA - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months edesabiotech.com|EDSA - Earnings per share growth rate in current year|Expected earnings per share growth for next year Edesa Biotech, Inc.
Basic company analysis:Edesa Biotech, Inc. (EDSA)
Fundamental asset screening requires precise measurement of capital efficiency. This indicator is calculated as the ratio of total annual net income to the number of shares outstanding. By analyzing the trend of annual net income per share, an investor assesses the real return of a single security. For Edesa Biotech, Inc. (EDSA), this metric indicates the ability to monetize antibody developments. Patent protection for such solutions will ensure a stable inflow of marginal cash flow in the future.
Direct competitors
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|Aurinia Pharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months BioCryst Corp|VERA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months DNTH|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AbCellera Biologics Inc ABCL|Earnings per share for the last twelve months Tourmaline Corp (TRML)|Net earnings per share for the last four quarters Precigen Corp|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|Net earnings per share (EPS TTM) nektar.com NKTR|UPB: Net earnings per share for the last 12 months|Earnings per share for the trailing year ZBIO (Zenas Bio)|IMNM: Net earnings per share (EPS TTM)|GOSS (Gossamer Bio Corp.) - Earnings per share for the last twelve months|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|septerna.com (SEPN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pieris Pharmaceuticals, Inc. (PVLA)|SVRA - Net earnings per one share for the last twelve months|Rigel Pharmaceuticals Inc - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ANAB (AnaptysBio Inc.)|Astria Therapeutics - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months engene.com|RAPT: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Aerovate Therapeutics|ACRS (Aclaris) - Net earnings per share (EPS TTM)|KYTX: Earnings per share for the trailing year|Net earnings per share for the last 12 months TLSA (Tiziana Life Sciences)|CABA (cabalettabio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) VTYX (Ventyx Biosciences, Inc.)|Net earnings per share for the last four quarters Theratechnologies, Inc. (THTX)|AVTX - Earnings per share for the last twelve months|ELDN (Eledon Pharmaceuticals, Inc) - Earnings per share for the last 12 months|AGEN: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months climbbio.com|Net earnings per share for the last 12 months ZURA|aTyr Pharma Inc (ATYR) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) ADAG|IMA - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) STTK (Shattuck Labs)|EQ: Earnings per share for the last 12 months|CNTB - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Immunic, Inc. IMUX|ATRA: Net earnings per share (EPS TTM)|InflaRx (IFRX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months X4 Pharmaceuticals|Adicet - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CELU|INMB (INmune Bio Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) BRNS (Barinthus Bio)|Net earnings per share (EPS TTM) Kezar Life Sciences Inc KZR|SABS - Earnings per share for the last twelve months|Earnings per share for the trailing year AKTX (akaritx.com)|enlivex.com (ENLV) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Q32 Bio|GOVX (GeoVax Labs Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) iBio Corporation|Net earnings per share for the last 12 months CARM (Carisma Therapeutics)|XTLB (xtlbio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics, Inc.)|Net earnings per share for the last four quarters HCW Biologics, Inc. (HCWB)|APVO - Earnings per share for the last twelve months|AIM ImmunoTech, Inc. (AIM) - Net earnings per share for the last 12 months|aditxt.com (ADTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months gribio.com|Net earnings per share for the last 12 months XRTX|Net earnings per share (EPS TTM) Vyome Holdings Inc.|Earnings per share for the last twelve months Revelation Bio (REVB)|Indaptus Corp - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) SCNI (Scinai Immunotherapeutics)|CalciMedica Inc (CALI) - Net earnings per one share for the last twelve months|Affimed Therapeutics - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Allakos Inc.|HOOK: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months IGMS|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months oceanbiomedical.com OCEA|Earnings per share for the last twelve months TC BioPharm (TCBP)|Net earnings per share for the last four quarters Third Harmonic Bio Inc.
